Impaired lung compliance and DL, CO but no restrictive ventilatory defect in sarcoidosis

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1315-1322

  Boros, P W ^a   Enright, P L ^b   Quanjer, P H ^d   Borsboom, G J J M ^e   Wesolowski, S P ^a   Hyatt, R E ^c  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^b UNIVERSITY OF ARIZONA   (United States)

^c MAYO CLINIC   (United States)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diffusion capacity; Lung compliance; Pulmonary function tests; Restriction; Sarcoidosis

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CAPACITY; LUNG COMPLIANCE; LUNG DIFFUSION; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; SMOKING; TOTAL LUNG CAPACITY;

ADULT; CARBON MONOXIDE; FEMALE; HUMANS; LUNG; LUNG COMPLIANCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SARCOIDOSIS; SMOKING; TOTAL LUNG CAPACITY; VITAL CAPACITY; YOUNG ADULT;

EID: 78649723932     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00166809     Document Type: Article

References (45)

1. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Schwarz MI, King TE Jr, Raghu G. Approach to the evaluation and diagnosis of interstitial lung disease. In: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease. London, B.C. Decker, Inc., 2003; pp. 1-30.
3. Westall GP, Stirling RG, Cullinan P, et al. Sarcoidosis. In: Schwarz MI, King TE Jr., eds. Interstitial Lung Disease. London, B.C. Decker, Inc., 2003; pp. 332-386.
4. Schlueter DP, Immekus J, Stead WW. Relationship between maximal inspiratory pressure and total lung capacity (coefficient of retraction) in normal subjects and in patients with emphysema, asthma, and diffuse pulmonary infiltration. Am Rev Respir Dis 1967; 96: 656-665.
5. Gibson GJ, Pride NB, Davis J, et al. Exponential description of the static pressure-volume curve of normal and diseased lungs. Am Rev Respir Dis 1979; 120: 799-811.
6. O'Donnell DE, Fitzpatrick MF. Physiology of interstitial lung disease. In: Schwarz MI, King TE Jr., eds. Interstitial Lung Disease. London, B.C. Decker, Inc., 2003; pp. 54-74.
7. Levinson RS, Metzger LF, Stanley NN, et al. Airway function in sarcoidosis. Am J Med 1977; 62: 51-59.
8. Colp C. Sarcoidosis: course and treatment. Med Clin North Am 1977; 61: 1267-1278.
9. Kaneko K, Sharma OP. Airway obstruction in pulmonary sarcoidosis. Bull Eur Physiopathol Respir 1977; 13: 231-240.
10. Bechtel JJ, Starr T III, Dantzker DR, et al. Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981; 124: 759-761.
11. Lewis MI, Horak DA. Airflow obstruction in sarcoidosis. Chest 1987; 92: 582-584.
12. Sharma OP, Johnson R. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest 1988; 94: 343-346.
13. Cieslicki J, Zych D, Zielinski J. Airways obstruction in patients with sarcoidosis. Sarcoidosis 1991; 8: 42-44.
14. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-211.
15. Harrison BD, Shaylor JM, Stokes TC, et al. Airflow limitation in sarcoidosis: a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991; 85: 59-64.
16. Bradvik I, Wollmer P, Simonsson B, et al. Lung mechanics and their relationship to lung volumes in pulmonary sarcoidosis. Eur Respir J 1989; 2: 643-651.
17. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983; 52: 525-533.
18. Standardized lung function testing. Eur Respir J Suppl 1993; 16: 1-100.
19. Lung mechanics I: lung elasticity in: Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir 1983; 19: Suppl. 5, 28-32.
20. Falaschetti E, Laiho J, Primatesa P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004; 23: 456-463.
21. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J 1995; 8: 492-506.
22. Colebatch HJ, Greaves IA, Ng CK. Exponential analysis of elastic recoil and aging in healthy males and females. J Appl Physiol 1979; 47: 683-691.
23. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
24. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
25. Begin R, Renzetti AD Jr, Bigler AH, et al. Flow and age dependence of airway closure and dynamic compliance. J Appl Physiol 1975; 38: 199-207.
26. Boros PW, Franczuk M, Wesolowski S. Value of spirometry in detecting volume restriction in interstitial lung disease patients. Spirometry in interstitial lung diseases. Respiration 2004; 71: 374-379.
27. Kabitz HJ, Lang F, Walterspacher S, et al. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest 2006; 130: 1496-1502.
28. Sietsma K. Sarcoidosis and the diffusing capacity for carbon monoxide. Sarcoidosis 1990; 7: 12-14.
29. Boros P, Radwan L, Kowalski J. Static lung compliance (Cst) and diffusion lung capacity (DL,CO) as markers of lung function impairment in large group of non-restrictive interstitial lung diseases (ILD) patients. Am J Respir Crit Care Med 2002; 165: Suppl. 8, A139.
30. Robertson HT. Clinical application of pulmonary function and exercise tests in the management of patients with interstitial lung disease. Sem Respir Crit Care Med 1994; 15: 1-9.
31. Miller BH, Rosado-de-Christenson ML, McAdams HP, et al. Thoracic sarcoidosis: radiologic-pathologic correlation. Radiographics 1995; 15: 421-437.
32. De Troyer A, Yernault JC. Inspiratory muscle force in normal subjects and patients with interstitial lung disease. Thorax 1980; 35: 92-100.
33. Fulmer JD, Roberts WC, von Gal ER, et al. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63: 665-676.
34. Kanengiser LC, Rapoport DM, Epstein H, et al. Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance. Chest 1989; 96: 1036-1042.
35. Murphy DM, Hall DR, Petersen MR, et al. The effect of diffuse pulmonary fibrosis on lung mechanics. Bull Eur Physiopathol Respir 1981; 17: 27-41.
36. Yernault JC, de Jonghe M, De Coster A, et al. Pulmonary mechanics in diffuse fibrosing alveolitis. Bull Eur Physiopathol Respir 1975; 11: 231-244.
37. Jodoin G, Gibbs GW, Macklem PT, et al. Early effects of asbestos exposure on lung function. Am Rev Respir Dis 1971; 104: 525-535.
38. Davies NJ. Does the lung work? 4. What does the transfer of carbon monoxide mean? Br J Dis Chest 1982; 76: 105-124.
39. Keogh BA, Crystal RG. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest 1980; 78: 856-865.
40. Strom KE, Eklund AG. Smoking does not prevent the onset of respiratory failure in sarcoidosis. Sarcoidosis 1993; 10: 26-28.
41. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988; 43: 516-524.
42. Lynch JP III, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997; 18: 755-785.
43. Udwadia ZF, Pilling JR, Jenkins PF, et al. Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 1990; 45: 272-275.
44. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273.
45. Galetke W, Feier C, Muth T, et al. Reference values for dynamic and static pulmonary compliance in men. Respir Med 2007; 101: 1783-1789.